Evidence map›Paper›PMID 36401171›Full record

ArticleBMC cardiovascular disorders2022

Von Hippel-Lindau syndrome with a rare complication of dilated cardiomyopathy: a case report.

Ming Yu, Beibei Du, Shuai Yao, Jianghong Ma, Ping Yang

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cardiovascular disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Case Report: A novelFrontiers in endocrinology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ming YuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Xiantai, Street NO.126, Jilin, 130033, Changchun, China.
Beibei DuDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Xiantai, Street NO.126, Jilin, 130033, Changchun, China.
Shuai YaoDepartment of Neurology, China-Japan Union Hospital of Jilin University, Jilin Province, 130031, Changchun, China.
Jianghong MaDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Xiantai, Street NO.126, Jilin, 130033, Changchun, China. 790989241@qq.com.
Ping YangDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Xiantai, Street NO.126, Jilin, 130033, Changchun, China. pyang@jlu.edu.cn.ORCID 0000-0001-7960-6248
Union Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVon Hippel-Lindau (VHL) syndrome is an autosomal dominant hereditary disease affecting multiple organs, with pheochromocytoma in 26% of cases. However, VHL syndrome with congestive heart failure and dilated cardiomyopathy as the primary clinical manifestations has been rarely reported. CASE PRESENTATION: A 35-year-old male patient was admitted to the hospital with dyspnea. The patient had a history of cerebellar hemangioblastoma that had been resected, and a one-year history of hypertension. Echocardiography and cardiac magnetic resonance imaging demonstrated a dilated left ventricle, decreased systolic function, and nonischemic myocardial changes. Contrast-enhanced abdominal computed tomography showed pheochromocytoma, neoplastic lesions, and multiple cysts in the kidneys and pancreas. Genetic analysis revealed a missense mutation of the VHL gene, c.269 A > T (p.Asn90Ile), which was identified as the cause of the disease. Dilated cardiomyopathy and VHL syndrome type 2 were diagnosed. The patient was administered a diuretic, α-blocker, β-blocker, and an angiotensin receptor neprilysin inhibitor (ARNI), but refused pheochromocytoma resection. At the six-month follow-up, the patient was asymptomatic with improved cardiac function.

conclusionCardiac involvement is an atypical manifestation in VHL syndrome. Early diagnosis with genetic screening is essential for avoiding life-threatening complications associated with VHL. The management of this rare manifestation of VHL syndrome requires further investigation.

Indexed as

Adrenal Gland NeoplasmsCardiomyopathy, DilatedPheochromocytomavon Hippel-Lindau DiseaseAdultGenetic TestingHumansMaleCase reportCongestive heart failureDilated cardiomyopathyPheochromocytomaVon Hippel–Lindau syndrome

Identifiers

PMID36401171
PMCPMC9673439
OpenAlexW4309466175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.